Clinical Trials Browser

Phase 2/3 × INDUSTRY × Sarcoma × Clear all

NCT02379845 2021-04-06

NBTXR3 Crystalline Nanoparticles and Radiation Therapy in Treating Randomized Patients in Two Arms With Soft Tissue Sarcoma of the Extremity and Trunk Wall

Phase 2/3 Completed

Sarcoma

NCT02449343 2017-04-25

Study of Anlotinib in Patients With Soft Tissue Sarcoma（STS）(ALTER0203)

Phase 2/3 Unknown

Sarcoma

NCT00243685 2012-01-26

Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis

Phase 2/3 Completed

BreastGynecologicSarcomaThoracic

Breast Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Sarcoma